Virtus LifeSci Biotech Clinical Trials ETF

Virtus LifeSci Biotech Clinical Trials ETF
  • Pininvest Analysis

About - Virtus Investment Partners VRTS/NASDAQ is a premier provider of investment solutions to individuals, financial advisors, and institutions. We aim to offer distinguished strategies and original perspectives to help our clients achieve better outcomes

Virtus ETF Solutions is an industry leader in subadvised exchange traded funds

Virtus LifeSci Biotech Clinical Trials ETF  BBC/NYSEARCA invests in clinical trials stage biotechnology companies. Clinical Trials stage companies are typically younger, smaller companies which do not have a drug approved, but instead focus on testing their experimental drug candidates in human clinical trials

LifeSci Index Partners, LLC is a New York-based index provider of healthcare-based stock market indices. The LifeSci team is comprised of investment professionals with experience in biotechnology equity research, in organic chemistry research in academia, and at pharmaceutical and biotechnology companies

Note from DATAvariance
The complete list of the 83 BBC constituents on the theme are not weighted; performance and volatility are calculated for informative purpose only - assuming one share of each component had been invested at the beginning of the selected period

For actual performance of the fund, which maybe higher or lower, depending on the weighting and trades decided by the provider, please check the information available on the Virtus LifeSci Clinical Trials ETF site or contact your advisor

More about Virtus LifeSci Biotech Clinical Trials ETF

Virtus LifeSci Biotech Clinical Trials ETF • Updated:

Name Ticker Exchange Sector Industry Currency Cur.Price Mkt.Cap Perf. Vol. Vol. Contrib. MDD
 
Abeona Therapeutics ABEO NASDAQ Health Care Biopharmaceuticals USD 8.09 388 M -42.1% 75%   1% -70%
Acceleron Pharma XLRN NASDAQ Health Care Biopharmaceuticals USD 46.91 2.4 B 10.1% 56%   1% -33%
Achaogen Inc AKAO NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 0.55 25 M -95.1% 106%   0% -97%
Achillion Pharmaceuticals ACHN NASDAQ Health Care Drug Manufacturers - Diversified USD 3.06 424 M -20.9% 72%   1% -67%
Aduro Biotech ADRO NASDAQ Health Care Biopharmaceuticals USD 4.00 298 M -56.8% 83%   1% -74%
Agenus Inc. AGEN NASDAQ Health Care Biopharmaceuticals USD 2.88 346 M -49.9% 74%   1% -72%
Agios Pharmaceuticals AGIO NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 64.84 3.8 B -20.7% 53%   1% -57%
Aimmune Therapeutics AIMT NASDAQ Health Care Biopharmaceuticals USD 22.40 1.4 B -27.5% 52%   1% -35%
Akebia Therapeutics, Inc. AKBA NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 8.17 466 M -32.8% 61%   1% -56%
Alder BioPharmaceuticals ALDR NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 13.71 939 M -1.4% 58%   1% -51%
Alnylam Pharmaceuticals ALNY NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 90.24 10 B -38.4% 54%   1% -58%
Amicus Therapeutics Inc. FOLD NASDAQ Health Care Drug Manufacturers - Diversified USD 13.53 3.0 B -6.7% 55%   1% -51%
AnaptysBio ANAB NASDAQ Health Care Biopharmaceuticals USD 73.00 2.0 B -33.3% 56%   1% -52%
Ardelyx ARDX NASDAQ Health Care Biopharmaceuticals USD 3.28 205 M -38.7% 70%   1% -71%
Arena Pharmaceuticals ARNA NASDAQ Health Care Biopharmaceuticals USD 45.98 2.3 B 48.9% 56%   2% -34%
Array BioPharma ARRY NASDAQ Health Care Biopharmaceuticals USD 23.74 5.2 B 44.4% 52%   2% -35%
Assembly Biosciences ASMB NASDAQ Health Care Biopharmaceuticals USD 19.64 502 M -66.5% 61%   0% -69%
Atara Biotherapeutics ATRA NASDAQ Health Care Biopharmaceuticals USD 39.18 1.8 B 1.3% 63%   2% -45%
Athenex ATNX NASDAQ Health Care Drug Manufacturers - Diversified USD 12.40 831 M -25.8% 50%   1% -49%
Audentes Therapeutics BOLD NASDAQ Health Care Biopharmaceuticals USD 38.50 1.7 B 34.1% 66%   2% -57%
AVEO Pharmaceuticals Inc. AVEO NASDAQ Health Care Clinical trial work USD 0.61 85 M -79.0% 122%   0% -85%
AveXis AVXS NASDAQ Health Care Biopharmaceuticals USD 217.83 8.0 B 75.3% 60%   1% -9%
Axovant Sciences AXON NASDAQ Health Care Biopharmaceuticals USD 1.22 190 M -17.6% 134%   1% -81%
BeiGene, Ltd BGNE NASDAQ Health Care Gene Editing - Cell Therapies USD 135.00 8.1 B -17.5% 52%   1% -51%
Bellicum Pharmaceuticals BLCM NASDAQ Health Care Biopharmaceuticals USD 3.56 158 M -55.6% 66%   1% -71%
BioCryst Pharmaceuticals BCRX NASDAQ Health Care Biopharmaceuticals USD 8.12 895 M 58.6% 54%   2% -26%
bluebird bio, Inc. BLUE NASDAQ Health Care Biopharmaceuticals USD 156.17 8.6 B -19.9% 54%   1% -54%
Blueprint Medicines Corp BPMC NASDAQ Health Care Biopharmaceuticals USD 82.64 3.6 B -17.6% 59%   1% -56%
Calithera Biosciences CALA NASDAQ Health Care Biopharmaceuticals USD 6.58 256 M -5.3% 61%   1% -51%
Cara Therapeutics, Inc. CARA NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 19.06 754 M 58.3% 61%   2% -48%
Celldex Therapeutics, Inc. CLDX NASDAQ Health Care Biopharmaceuticals USD 4.77 59 M -86.7% 139%   0% -92%
Corbus Pharmaceuticals Holdings CRBP NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 6.87 442 M -2.6% 79%   1% -36%
Cymabay Therapeutics CBAY NASDAQ Health Care Clinical trial work USD 13.35 794 M -1.3% 62%   2% -55%
Cytokinetics Inc. CYTK NASDAQ Health Care Biopharmaceuticals USD 8.23 452 M -5.4% 63%   1% -40%
CytomX Therapeutics CTMX NASDAQ Health Care Biopharmaceuticals USD 10.75 485 M -68.1% 73%   1% -72%
Dova Pharmaceuticals DOVA NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 8.98 253 M -64.1% 92%   0% -83%
Epizyme, Inc. EPZM NASDAQ Health Care Biopharmaceuticals USD 12.27 972 M -34.2% 73%   1% -73%
Esperion Therapeutics ESPR NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 48.53 1.3 B -34.4% 76%   1% -53%
FibroGen FGEN NASDAQ Health Care Biopharmaceuticals USD 55.68 4.8 B 11.2% 47%   1% -44%
Five Prime Therapeutics FPRX NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 12.99 461 M -21.0% 57%   1% -59%
G1 Therapeutics GTHX NASDAQ Health Care Biopharmaceuticals USD 16.02 599 M -57.3% 84%   1% -77%
Geron GERN NASDAQ Health Care Drug Manufacturers - Diversified USD 1.64 306 M -62.2% 136%   1% -85%
Global Blood Therapeutics GBT NASDAQ Health Care Biopharmaceuticals USD 52.89 3.0 B -2.3% 68%   1% -42%
GlycoMimetics GLYC NASDAQ Health Care Clinical trial work USD 12.54 541 M -25.2% 54%   1% -56%
Idera Pharmaceuticals IDRA NASDAQ Health Care Biopharmaceuticals USD 3.12 86 M -79.5% 109%   0% -86%
Immunogen IMGN NASDAQ Health Care Biopharmaceuticals USD 2.59 387 M -78.5% 94%   0% -81%
Immunomedics, Inc. IMMU NASDAQ Health Care Biopharmaceuticals USD 18.84 3.6 B 21.5% 66%   2% -51%
Inovio Pharmaceuticals INO NASDAQ Health Care Biopharmaceuticals USD 3.52 344 M -31.1% 56%   1% -45%
Insmed INSM NASDAQ Health Care Biopharmaceuticals USD 29.75 2.3 B 22.4% 75%   2% -61%
Intra-Cellular Therapies, Inc. ITCI NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 12.82 707 M -45.2% 55%   1% -56%
Iovance Biotherapeutics IOVA NASDAQ Health Care Biopharmaceuticals USD 10.35 1.3 B -37.3% 72%   1% -58%
Jounce Therapeutics JNCE NASDAQ Health Care Immunotherapy USD 6.60 218 M -75.7% 99%   0% -90%
Karyopharm Therapeutics Inc. KPTI NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 5.31 323 M -65.2% 87%   1% -81%
Kura Oncology KURA NASDAQ Health Care Biopharmaceuticals USD 15.96 609 M -20.2% 55%   1% -51%
La Jolla Pharmaceutical LJPC NASDAQ Health Care Biopharmaceuticals USD 7.29 197 M -74.8% 95%   0% -85%
Loxo Oncology LOXO NASDAQ Health Care Biopharmaceuticals USD 234.66 7.2 B 98.2% 70%   3% -33%
MacroGenics MGNX NASDAQ Health Care Biopharmaceuticals USD 19.08 931 M -34.6% 101%   1% -62%
Madrigal Pharmaceuticals MDGL NASDAQ Health Care Biopharmaceuticals USD 143.66 2.2 B 18.5% 113%   2% -70%
Marinus Pharmaceuticals MRNS NASDAQ Health Care Clinical trial work USD 3.85 202 M -5.9% 81%   1% -76%
Melinta Therapeutics MLNT NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 5.09 57 M -90.3% 111%   0% -93%
Mirati Therapeutics, Inc. MRTX NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 76.29 2.7 B 136.2% 64%   4% -49%
MyoKardia MYOK NASDAQ Health Care Biopharmaceuticals USD 53.86 2.2 B 8.8% 48%   1% -41%
NewLink Genetics NLNK NASDAQ Health Care Biopharmaceuticals USD 1.89 482 M -72.7% 83%   0% -82%
Novavax NVAX NASDAQ Health Care Biopharmaceuticals USD 0.52 199 M -75.1% 129%   0% -79%
Paratek Pharmaceuticals PRTK NASDAQ Health Care Biopharmaceuticals USD 6.25 203 M -54.9% 55%   0% -65%
Pieris Pharmaceuticals PIRS NASDAQ Health Care Biopharmaceuticals USD 3.34 181 M -53.7% 61%   1% -68%
Prothena Corp plc PRTA NASDAQ Health Care Biopharmaceuticals USD 14.49 578 M -56.3% 130%   1% -80%
PTC Therapeutics PTCT NASDAQ Health Care Biopharmaceuticals USD 36.94 2.2 B 22.6% 69%   1% -41%
Reata Pharmaceuticals RETA NASDAQ Health Care Biopharmaceuticals USD 95.12 2.8 B 318.1% 78%   7% -47%
REGENXBIO RGNX NASDAQ Health Care Gene Editing - Cell Therapies USD 58.36 2.1 B 100.5% 69%   4% -52%
Rigel Pharmaceuticals RIGL NASDAQ Health Care Biopharmaceuticals USD 2.57 430 M -38.8% 64%   1% -52%
SAGE Therapeutics SAGE NASDAQ Health Care Biopharmaceuticals USD 156.88 7.4 B -5.7% 67%   2% -53%
Sangamo Therapeutics SGMO NASDAQ Health Care Gene Editing - Cell Therapies USD 9.80 1.0 B -57.6% 86%   1% -68%
Seres Therapeutics MCRB NASDAQ Health Care Biopharmaceuticals USD 6.57 270 M -26.3% 67%   1% -53%
Stemline Therapeutics STML NASDAQ Health Care Biopharmaceuticals USD 12.90 562 M -8.5% 56%   1% -58%
Tetraphase Pharmaceuticals TTPH NASDAQ Health Care Drug Manufacturers - Diversified USD 1.36 73 M -56.7% 63%   1% -76%
TG Therapeutics TGTX NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 7.41 621 M -53.5% 87%   1% -79%
Ultragenyx Pharmaceutical Inc. RARE NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 68.36 3.5 B 36.2% 56%   2% -57%
uniQure QURE NASDAQ Health Care Gene Editing - Cell Therapies USD 65.78 2.5 B 216.6% 75%   6% -47%
Voyager Therapeutics VYGR NASDAQ Health Care Biopharmaceuticals USD 18.90 616 M -10.2% 75%   1% -67%
Xencor XNCR NASDAQ Health Care Clinical trial work USD 30.42 1.7 B -4.1% 49%   1% -42%
ZIOPHARM Oncology ZIOP NASDAQ Health Care Biopharmaceuticals USD 3.85 625 M -12.5% 79%   1% -67%